Search

Memorial Sloan Kettering, one of the nation’s top cancer treatment and research institutions, is expanding its reach on Long Island with a new 114,000-square-foot freestanding cancer treatment center in Nassau County. Once complete, MSK Nassau will house the area’s most comprehensive cancer care program, centrally located and staffed by the most forward-thinking and compassionate healthcare teams whose sole focus is caring for people with cancer.

A simple blood test performed at age 60 can determine a man's risk of dying from prostate cancer within the next 25 years, according to a new study led by Memorial Sloan Kettering Cancer Center investigators. The study's findings suggest that regular prostate-specific antigen (PSA) screening for prostate cancer should be focused on men who receive high readings from a PSA test performed at age 60 and that men with low readings can be spared further screening.

Learn why surgery remains a very effective treatment for most prostate cancers.

As a tribute to Memorial Sloan Kettering Board member Josephine “Josie” Robertson, Memorial Sloan Kettering has joined with The Robertson Foundation to undertake two high-profile initiatives — the Josie Robertson Surgery Center and the Josie Robertson Investigators Program — made possible by a $50 million commitment from The Robertson Foundation.

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer discovery during the American Association for Cancer Research (AACR) Annual Meeting on April 5-10 in San Diego, California.

Investigators have employed mutant mice to study how the accumulation of genetic errors is managed during egg and sperm formation.

Ingo K. Mellinghoff, MD, FACP, neuro-oncologist and Chair of the Department of Neurology, presented significant results from a phase III trial in patients with residual or recurrent grade 2 glioma with an IDH1/2 mutation.

Read about Josh Foromera, who was born in a small village in Zimbabwe and recently began a fellowship in the Gastroenterology, Hepatology, and Nutrition Service at MSK.